Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sandoz Does Not Budge On 2022 Expectations Despite Positive Start
Q1 Revenues Improve By 8% At CCs While Bottom Line Soars – With Caveats
Apr 27 2022
•
By
Dean Rudge
Sandoz enjoyed a huge bump in its core operating profit in Q1 • Source: Shutterstock
More from Earnings
More from Business